FIELD: chemistry.
SUBSTANCE: present invention relates to pyrrolo{2,3-d}pyrimidine derivatives
or pharmaceutically acceptable salts thereof, as well as to pharmaceutical compositions containing said compounds.
EFFECT: novel pyrrolo{2,3-d}pyrimidine derivatives which can be used to inhibit Janus kinase (JAK) and are applicable in methods of treating conditions mediated by JAK1 are obtained.
6 cl, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
| TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
| BISULFATE OF JANUS KINAZE (JAK) INHIBITOR AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2665680C2 |
| PYRROLOPYRIMIDINE COMPOUNDS FOR MALIGNANT TUMOUR TREATMENT | 2012 |
|
RU2631655C2 |
| 4-AMINO-5-PHENYL-7-CYCLOBUTYLPYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2002 |
|
RU2305682C2 |
| AMINOPYRIMIDINYL DERIVATIVES | 2021 |
|
RU2817349C1 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| COMPOUNDING, WHICH INHIBITES ACTIVITY OF BTK AND/OR JAK3 KINASES | 2014 |
|
RU2650512C2 |
| TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
